배경 : 본 연구는 건강검진자에서 공복혈당에 따른 고감도 C-반응성 단백질(high sensitivity C-reactive protein, hsCRP) 및대사증후군 발생에 대하여 알아보고, 특히, 현재 정상공복혈당으로 분류되는 1...
http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
https://www.riss.kr/link?id=A101631141
2006
-
KCI등재,SCIE,SCOPUS
학술저널
454-459(6쪽)
1
0
상세조회0
다운로드국문 초록 (Abstract)
배경 : 본 연구는 건강검진자에서 공복혈당에 따른 고감도 C-반응성 단백질(high sensitivity C-reactive protein, hsCRP) 및대사증후군 발생에 대하여 알아보고, 특히, 현재 정상공복혈당으로 분류되는 1...
배경 : 본 연구는 건강검진자에서 공복혈당에 따른 고감도 C-반응성 단백질(high sensitivity C-reactive protein, hsCRP) 및대사증후군 발생에 대하여 알아보고, 특히, 현재 정상공복혈당으로 분류되는 110 mg/dL 미만군을 100 mg/dL 미만군과 그 이상의 군으로 이분하고, 이들 군 사이에 hsCRP 및 대사증후군 발생에 어떤 차이가 있는지 밝히고자 하였다. 방법 : 20세 이상 남자 3,221명, 여자 3,334명의건강검진자를대상으로 공복혈당에 따라 정상 I군(100 mg/dL 미만 군), 정상
참고문헌 (Reference)
1 "The pathogenesis of atherosclerosis:a perspective for the1990s" 362 : 801-9, 1993
2 "The metabolic syndrome and risk of major coronary eventsin the Scandinavian Simvastatin Survival Study(4S)and the AirForce/Texas Coronary Atherosclerosis Prevention Study" 93 : 136-141, 2004
3 "Should C-reactive protein beadded to metabolic syndrome and to assessment of global cardio-vascular risk?" 109 : 2818-2825, 2004
4 "Serum lipoprotein(a)levels in patients with diabetic foot lesions" 71 : 119-123, 2006
5 "Relation of C-reac-tive protein to features of the metabolic syndrome in normal glu-cose tolerant,impaired glucose tolerant,and newly diagnosed type2 diabetic subjects" 29 : 65-71, 2003
6 "Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women:a report from the Women's Ischemia Syndrome Evaluation" 109 : 714-721, 2004
7 "Markers of inflammation and cardiovasculardisease application to clinical and public health practice A statementfor healthcare professionals from the Centers for Disease Controland Prevention and the American Heart Association" 107 : 499-511, 2003
8 "Lipoprotein(a) is an independent risk factor for periph-eral arterial disease in Chinese type 2 diabetic patients in Taiwan" 27 : 517-521, 2004
9 "Inflammatory pathways in atherosclerosis and acute coro-nary syndromes" 88 : 10-15, 2001
10 "Hy-perglycemia-induced production of acute phase reactants in adiposetissue" 276 : 42077-42083, 2001
1 "The pathogenesis of atherosclerosis:a perspective for the1990s" 362 : 801-9, 1993
2 "The metabolic syndrome and risk of major coronary eventsin the Scandinavian Simvastatin Survival Study(4S)and the AirForce/Texas Coronary Atherosclerosis Prevention Study" 93 : 136-141, 2004
3 "Should C-reactive protein beadded to metabolic syndrome and to assessment of global cardio-vascular risk?" 109 : 2818-2825, 2004
4 "Serum lipoprotein(a)levels in patients with diabetic foot lesions" 71 : 119-123, 2006
5 "Relation of C-reac-tive protein to features of the metabolic syndrome in normal glu-cose tolerant,impaired glucose tolerant,and newly diagnosed type2 diabetic subjects" 29 : 65-71, 2003
6 "Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women:a report from the Women's Ischemia Syndrome Evaluation" 109 : 714-721, 2004
7 "Markers of inflammation and cardiovasculardisease application to clinical and public health practice A statementfor healthcare professionals from the Centers for Disease Controland Prevention and the American Heart Association" 107 : 499-511, 2003
8 "Lipoprotein(a) is an independent risk factor for periph-eral arterial disease in Chinese type 2 diabetic patients in Taiwan" 27 : 517-521, 2004
9 "Inflammatory pathways in atherosclerosis and acute coro-nary syndromes" 88 : 10-15, 2001
10 "Hy-perglycemia-induced production of acute phase reactants in adiposetissue" 276 : 42077-42083, 2001
11 "Follow-up report on the diagnosis of diabetes mellitus" 26 : 3160-3167, 2003
12 "Effects of interleukin-6 on proliferation andfollicle-stimulating hormone-induced estradiol production by bovinegranulosa cells in vitro:dependence on size of follicle" 50 : 38-43, Reprod1994
13 "Effect of increasing metabolic syndrome score onatherosclerotic risk profile and coronary artery disease angiographic severity" 93 : 159-164, 2004
14 "Clinical usefulness of very high and verylow levels of C-reactive protein across the full range of FraminghamRisk Scores" 109 : 1955-1959, 2004
15 "Clinical application of C-reactive protein for cardiovas-cular disease detection and prevention" 107 : 363-369, 2003
16 "CDC/AHA workshop on markers of inflammationand cardiovascular disease:Application to clinical and public healthpractice laboratory tests available to assess inflammation-perfor-mance and standardization" 110 : 572-576, 2004
17 "C-reactive protein,themetabolic syndrome,and risk of incident cardiovascular events:an8-year follow-up of 14719 initially healthy American women" 107 : 391-397, 2003
18 "C-reactive protein is an independent predictor of risk for the devel-opment of diabetes in the west of Scotland coronary preventionstudy" 51 : 1596-1600, 2002
19 "C-reactive protein as a cardiovascular risk factor:more than an epiphenomenon?" 100 : 96-102, 1999
20 "Atherosclerosis-an inflammatory disease" 340 : 115-126, 1999
21 "Associations of C-reactive protein with mea-sures of obesity, insulin resistance, and subclinical atherosclerosis inhealthy, middle-aged women" 19 : 1986-1991, 1999
22 "Association of the metabolic syndrome with history of myocardialinfarction and stroke in the Third National Health and NutritionExamination Survey" 109 : 42-46, 2004
23 "Association between fastingglucose and C-reactive protein in a Japanese population:the Minohstudy" 69 : 88-98, 2005
24 "Association between fasting glucose and C-reactive proteinin middle-aged subjects" 21 : 39-44, 2004
25 "A pro-spective study of lipoprotein(a) and risk of coronary heart diseaseamong women with type 2 diabetes" 48 : 2691-2692, 2005
세 가지 검사 시약에 따른 Anti-HBs 검사의 정성 및 정량적 비교 분석
Clostridium difficile 독소 A 검출을 위한 효소면역법의 비교
Six Sigma Metrics를 이용한 Bayer Rapidpoint 400 혈액가스 및 전해질분석장비의 고정 정도관리 범위의 평가
급성백혈병의 Lineage Assignment에 있어서 면역표현형 표지자의 적정 개수
학술지 이력
연월일 | 이력구분 | 이력상세 | 등재구분 |
---|---|---|---|
2023 | 평가예정 | 해외DB학술지평가 신청대상 (해외등재 학술지 평가) | |
2020-01-01 | 평가 | 등재학술지 유지 (해외등재 학술지 평가) | |
2012-05-21 | 학술지명변경 | 한글명 : The Korean Journal of Laboratory Medicine -> Annals of Laboratory Medicine외국어명 : The Korean Journal of Laboratory Medicine -> Annals of Laboratory Medicine | |
2011-01-01 | 평가 | 학술지 분리 (기타) | |
2010-06-29 | 학술지명변경 | 한글명 : 대한진단검사의학회지 -> The Korean Journal of Laboratory Medicine | |
2009-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2007-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2005-01-01 | 평가 | 등재학술지 유지 (등재유지) | |
2002-01-01 | 평가 | 등재학술지 선정 (등재후보2차) | |
1999-07-01 | 평가 | 등재후보학술지 선정 (신규평가) |
학술지 인용정보
기준연도 | WOS-KCI 통합IF(2년) | KCIF(2년) | KCIF(3년) |
---|---|---|---|
2016 | 1.51 | 0.18 | 1.15 |
KCIF(4년) | KCIF(5년) | 중심성지수(3년) | 즉시성지수 |
0.91 | 0.81 | 0.458 | 0.08 |